lifestyle.longislandreport.org

Almirall Presents Long-Term Results from First Real-World Dermatology Study Using WHO-5 Well-Being Index as Primary Endpoint in the treatment of Psoriasis at EADV 2025

Written by

businesswire

Almirall Presents Long-Term Results from First Real-World Dermatology Study Using WHO-5 Well-Being Index as Primary Endpoint in the treatment of Psoriasis at EADV 2025 – NEWSnet – News… as it used to be


More Press Releases